Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, Dec. 8, 2023.
Beta Bionics became the second company in as many days to launch an automated insulin pump with the Dexcom G7 CGM. Fast Five hosts Jim Hammerand and Sean Whooley dive into the latest news and break down the key features of the iLet bionic pancreas.
Distalmotion selected a former Zimmer Biomet executive to take over as its new CEO. The hosts look into the background of the new figure in the corner office and discuss the Dexter surgical robot platform as the company prepares for its next phase of growth.
BD has a new alternative to the traditional venous blood drawing method following FDA clearance for its MiniDraw device. Hammerand and Whooley explain what sets this device apart from other methods and why it could usher in a new era of diagnostics.
Medtronic made waves earlier this year when it agreed to acquire insulin patch pump maker EOFlow, but that deal is now off after the medtech giant terminated their acquisition agreement. The hosts discuss the reasons behind Medtronic’s decisions and the potential ramifications on the insulin delivery market.
Edwards is the latest big-name medtech company to join the spin-off trend, announcing plans to spin its critical care business. Hammerand and Whooley take a look at Edwards’ reasoning behind the decision and the areas in which the company now plans to focus once it completes the separation.
Follow the Fast Five hosts on LinkedIn
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.
